公司概覽
業務類別 Medical Devices
業務概覽 Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
公司地址 300 Boston Scientific Way, Marlborough, MA, USA, 01752-1234
電話號碼 +1 508 683-4000
傳真號碼 +1 508 650-8923
公司網頁 https://www.bostonscientific.com
員工數量 59000
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Ms. Miriam O’Sullivan Senior Vice President and Chief Human Resources Officer -- 18/03/2026
Mr. Vance R. Brown Executive Vice President, General Counsel and Corporate Secretary 美元 659.09K 18/03/2026
Mr. Jonathan R. Monson Executive Vice President and Chief Financial Officer 美元 591.85K 18/03/2026
Mr. Joseph M. Fitzgerald Executive Vice President and Group President, Cardiovascular 美元 892.60K 18/03/2026
Mr. Michael F. Mahoney Chairman of the Board, President and Chief Executive Officer 美元 1.44M 18/03/2026
Mr. Arthur C. Butcher Executive Vice President and Group President, MedSurg and Asia Pacific 美元 744.82K 18/03/2026
Mr. Padraig A. O’Connor Executive Vice President, Global Operations -- 18/03/2026
Ms. Emily M. Woodworth Senior Vice President, Global Controller and Chief Accounting Officer -- 18/03/2026
 
董事會成員
董事會 職務 更新日期
Mr. Edward J. Ludwig Lead Independent Director 18/03/2026
Mr. David S. Wichmann Independent Director 18/03/2026
Ms. Ellen M. Zane Independent Director 18/03/2026
Mr. Yoshiaki Fujimori Independent Director 05/02/2026
Senator John E. Sununu Independent Director 18/03/2026
Ms. Catherine R. Smith Independent Director 18/03/2026
Ms. Susan E. Morano Independent Director 18/03/2026
Mr. Michael F. Mahoney Chairman of the Board, President and Chief Executive Officer 18/03/2026
Dr. Jessica L. Mega, M.D.,M.P.H. Independent Director 18/03/2026
Mr. David C. Habiger Independent Director 18/03/2026
Mr. Christophe Pierre Weber Director 23/02/2026
Ms. Catherine R. Smith Director 23/02/2026
Dr. Cheryl B. Pegus, M.D. Independent Director 18/03/2026
 
所屬ETF (更新日期: 02/05/2026 02:34)
代號 名稱 佔比% 持有日期
DXUVDimensional US Vector Equity ETF<0.000001%02/04/2026
EEECyber Hornet S&P 500®AndEth75/25StrETF<0.000001%29/04/2026
EHLSEven Herd Long Short ETF<0.000001%18/08/2025
ENDWCambria Endowment Style ETF<0.000001%26/02/2026
ESGUiShares ESG Aware MSCI USA ETF<0.000001%24/11/2025
FADFirst Trust Multi Cap Gr AlphaDEX® ETF<0.000001%08/04/2026
FBUFFidelity Dynamic Buffered Equity ETF<0.000001%20/02/2026
FDIFFidelity Disruptors ETF<0.000001%02/03/2026
FDMOFidelity Momentum Factor ETF<0.000001%21/11/2025
FEACFidelity Enhanced U.S. All-Cap Eq ETF<0.000001%20/04/2026
FELCFidelity Enhanced Large Cap Core ETF<0.000001%20/02/2026
FELVFidelity Enhanced Large Cap Value ETF<0.000001%24/04/2026
FEXFirst Trust Large Cap Core AlphaDEX® ETF<0.000001%08/04/2026
FHEQFidelity Hedged Equity ETF<0.000001%20/02/2026
FLCVFederated Hermes MDT Large Cap Value ETF<0.000001%24/10/2025
FLQLFranklin US Large Cap Mltfctr Idx ETF<0.000001%22/12/2025
FLSPFranklin Systematic Style Premia ETF<0.000001%17/02/2026
FRTYAlger Mid Cap 40 ETF<0.000001%16/01/2026
FTCFirst Trust Large Cap Gr AlphaDEX® ETF<0.000001%08/04/2026
FTCEFirst Trust New Cstrcts Cr Erns Ldrs ETF<0.000001%19/01/2026
  1    2    3    4    5    6    7    8    9    10    11    12    13    14    15    16    17    18   19    20    21    22    23  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.